We are live on ! Find out more
IGMS

IGM Biosciences
IGMS

Delisted

IGMS was delisted on the 13th of August, 2025.

Back to rankings

89 hedge funds and large institutions have $316M invested in IGM Biosciences in 2022 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 31 increasing their positions, 26 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

695% more call options, than puts

Call options by funds: $2M | Put options by funds: $252K

19% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 26

4% less funds holding

Funds holding: 93 → 89 (-4)

6.23% less ownership

Funds ownership: 70.11% → 63.87% (-6.2%)

11% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 19

35% less capital invested

Capital invested by funds: $487M → $316M (-$172M)

Holders
89
Holders Change
-4
Holders Change %
-4.3%
% of All Funds
1.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
31
Reduced
26
Closed
19
Calls
$2M
Puts
$252K
Net Calls
+$1.75M
Net Calls Change
-$5.36M

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$6.72M
2
Millennium Management
Millennium Management
New York
+$6.56M
3
Marshall Wace
Marshall Wace
United Kingdom
+$3.47M
4
Victory Capital Management
Victory Capital Management
Texas
+$1.26M
5
N
Nuveen
North Carolina
+$1.09M

Top Sellers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
-$10.8M
2
EC
EcoR1 Capital
California
-$7.98M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$5.69M
4
Goldman Sachs
Goldman Sachs
New York
-$4.09M
5
WP
Woodline Partners
California
-$3.62M
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
76
Aquatic Capital Management
Illinois
$11K -$1.78K -100 -14%
AIP
77
Ameritas Investment Partners
Nebraska
$11K – – –
Canada Life
78
Canada Life
Manitoba, Canada
$10K – – –
Macquarie Group
79
Macquarie Group
Australia
$10K – – –
Wells Fargo
80
Wells Fargo
California
$7K +$5.28K +296 +237%
SOW
81
State of Wyoming
Wyoming
$5K -$21.8K -1,224 -82%
EWM
82
Endurance Wealth Management
Rhode Island
$5K – – –
Fidelity Investments
83
Fidelity Investments
Massachusetts
$5K +$909 +51 +20%
PP
84
PFS Partners
New Jersey
$4.15K +$4.1K +230 New
QCG
85
Quadrant Capital Group
Ohio
$2K -$1.37K -77 -45%
Daiwa Securities Group
86
Daiwa Securities Group
Japan
$2K – – –
PFS
87
Prospera Financial Services
Texas
$2K – – –
EI
88
Ellevest Inc
New York
$2K +$1.48K +83 +1,038%
ED
89
Exane Derivatives
France
$865 – – –
CAM
90
Cormorant Asset Management
Massachusetts
– -$10.8M -402,200 Closed
EC
91
EcoR1 Capital
California
– -$7.98M -298,597 Closed
IM
92
Islet Management
New York
– -$3.52M -131,700 Closed
State of Wisconsin Investment Board
93
State of Wisconsin Investment Board
Wisconsin
– -$1.17M -43,800 Closed
Squarepoint
94
Squarepoint
New York
– -$957K -35,808 Closed
OQS
95
Occudo Quantitative Strategies
Florida
– -$733K -27,408 Closed
HT
96
HAP Trading
New York
– -$610K -22,814 Closed
Susquehanna International Group
97
Susquehanna International Group
Pennsylvania
– -$331K -18,578 Closed
Two Sigma Investments
98
Two Sigma Investments
New York
– -$483K -18,057 Closed
Tudor Investment Corp
99
Tudor Investment Corp
Connecticut
– -$391K -14,639 Closed
SSA
100
Schonfeld Strategic Advisors
New York
– -$308K -11,500 Closed
1 2 3
4
5

IGMS Hedge Fund Activity: Q2 2022 in Review

89 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in IGM Biosciences (IGMS) for Q2 2022, worth a combined $316M — down 35% from $487M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of IGMS and 17 opened new positions — a net loss of 2 holders — while 26 trimmed existing stakes and 31 added.

The largest buyer was T. Rowe Price Associates, adding an estimated $6.72M. The largest seller was Cormorant Asset Management, exiting entirely with an estimated $10.8M sold.

  • 89 institutional investors held IGM Biosciences (IGMS) as of Q2 2022, down from 93 in Q1 2022.
  • Funds reported $316M of IGM Biosciences stock for Q2 2022, down 35% quarter-over-quarter.
  • 17 funds opened new IGM Biosciences positions in Q2 2022 and 19 closed out, a net change of -2 holders.
  • The largest IGM Biosciences buyer in Q2 2022 was T. Rowe Price Associates, an estimated $6.72M added.
  • The largest IGM Biosciences seller in Q2 2022 was Cormorant Asset Management, an estimated $10.8M sold.

Based on aggregated 13F filings for Q2 2022.